GlycoTreat Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

GlycoTreat General Information

Description

Developer of glycan-mediated allergen immunotherapy designed for treating allergies. The company's immunotherapy utilizes a glycan-mediated immune pathway by redirecting the immune system to develop lifelong tolerance towards specific antigens, enabling patients to cure allergies by manipulating cell surface glycans to suppress the immune system.

Contact Information

Website
www.glycotreat.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Koningin Beatrixplantsoen 28
  • 3818 ZB Amersfoort
  • Netherlands
+31 06
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Koningin Beatrixplantsoen 28
  • 3818 ZB Amersfoort
  • Netherlands
+31 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlycoTreat Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2026 Completed Generating Revenue
To view GlycoTreat’s complete valuation and funding history, request access »

GlycoTreat Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlycoTreat Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dactari Fund Venture Capital Minority
Innovatiefonds Noord-Holland Venture Capital Minority
To view GlycoTreat’s complete investors history, request access »

Ready to get started?

Request a free trial

GlycoTreat FAQs

  • When was GlycoTreat founded?

    GlycoTreat was founded in 2022.

  • Where is GlycoTreat headquartered?

    GlycoTreat is headquartered in Amersfoort, Netherlands.

  • What is the size of GlycoTreat?

    GlycoTreat has 6 total employees.

  • What industry is GlycoTreat in?

    GlycoTreat’s primary industry is Biotechnology.

  • Is GlycoTreat a private or public company?

    GlycoTreat is a Private company.

  • What is GlycoTreat’s current revenue?

    The current revenue for GlycoTreat is .

  • Who are GlycoTreat’s investors?

    Dactari Fund and Innovatiefonds Noord-Holland have invested in GlycoTreat.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process